Common Contracts
1 similar Clinical Trial Agreement contracts
ContractClinical Trial Agreement • May 13th, 2020
Amendment # 1to Clinical Trial Agreement Protocol No. XXX Dodatek č. 1Ke Smlouvě o klinické studii Č. protokolu XXX This amendment (“Amendment”) is made by Tento dodatek („Dodatek“) vydává Celgene Corporation, having its principal office at86 Morris Avenue, Summit, NJ 07901, USA represented for the purposes of this Amendment by Celgene International II Sàrl, a limited liability company organized under the laws of Switzerland having its principal office at Rue du Pré-Jorat 14, 2108 Couvet, Switzerland,(hereinafter the “Sponsor”) andÚstav hematologie a krevní transfuze, p.o., with registered office at U Nemocnice 2094/1, 128 20 Prague, Czech RepublicID: 00023736 VAT ID: CZ00023736 Represented by prof. MUDr. Petr Cetkovský, Ph.D.,MBA, director (hereinafter the “Institution”); andXXX with address at XXX (hereinafter the “Investigator”); (together the “Parties”) Celgene Corporation se sídlem na adrese 86 Morris Avenue, Summit, NJ 07901, USA zastoupená pro účely tohoto dodatku Celgene Inte
